当前位置 : 首页 > 市场合作 > 项目信息市场合作
Market cooperation| 发包方名称 | National University Corporation - Shizuoka |
| 发包方国别(国家/地区) | 日本 |
| 发包方座机 | |
| 发包方传真 | |
| 发包方邮箱 | |
| 发包方地址 | Procurement Section, Medical Affairs Division, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku Hamamatsu-shi 431-3192 Japan |
| 发包方网址 | |
| 发包方联系人姓名 | Hiroyuki Ito |
| 发包方联系人座机 | 053-435-2132 |
| 发包方联系人手机 | |
| 发包方联系人邮箱 | |
| 项目名称 | Idursulfase beta(Genetical Recombination) (15㎎1mL×1vial/1case) 32 cases |
| 项目类型 | 其他 - 其他 |
| 项目预算¥ | |
| 项目投标截止时间 | 2021-07-16 |
| 项目开始时间 | |
| 项目结束时间 | |
| 服务商资质要求 | |
| 要求高匹配度成功案例个数 | |
| 项目交付地点 | |
| 是否准许转包或分包 | |
| 项目信息详述 |
⑴ Official in charge of disbursement of the procuring entity : Makoto Sato, Executive Director
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased : Idursulfase beta(Genetical Recombination) (15㎎1mL×1vial/1case) 32 cases
⑷ Delivery period : From 1 August, 2021 through 31 March, 2022
⑸ Delivery place : Hamamatsu University School of Medicine Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 2 and 3 of the Regulation concerning the Contract for Hamamatsu University School of Medicine Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause,
B have the Grade A, Grade B or Grade C qualification during fiscal 2021 in the Tokai・Hokuriku area in sales of product for participating in tenders by Single qualification for every ministry and agency,
C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the Obligating Officer,
E meet the qualification requirements which Executive Director may specify in accordance with Article 4 of the Regulation,
F not be currently under a suspension of business order as instructed by Executive Director.
⑺ Time limit of tender : 17 : 00 16 July, 2021
⑻ Contact point for the notice : Hiroyuki Ito, Procurement Section, Medical Affairs Division, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku Hamamatsu-shi 431-3192 Japan, TEL 053-435-2132
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.
|
版权所有:天津市数字贸易综合服务平台 备案号:津B2-20080229-9